KaloBios Pharmaceuticals Inc. (Nasdaq: KBIO) named Martin Shkreli to the position of chief executive officer sending the stock price soaring $7.81 to $18.21.
KaloBios names Martin Shkreli CEO
November 20, 2015 at 12:35 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.